Paragon 28 names Steve Deitsch company CFO

Paragon 28 names Steve Deitsch company CFO

ENGLEWOOD -- Paragon 28, Inc. announced the appointment of Steve Deitsch to the position of chief financial officer. Deitsch assumes responsibility for finance, accounting, human resources, and... Read More

Thursday October 8, 2020 0 comments Tags: Englewood, Paragon 28, Steve Deitsch, Albert DaCosta

Zynex growth leads to new manufacturing and warehouse facility

Zynex growth leads to new manufacturing and warehouse facility

ENGLEWOOD -- Zynex, Inc. (NASDAQ: ZYXI) today announced the lease of a new 50,488-square-foot warehouse facility for its growing manufacturing and inventory requirements. "With order growth of... Read More

Wednesday October 7, 2020 0 comments Tags: Englewood, Zynex, Thomas Sandgaard

FDA grants IND and approves clinical trial protocol of inhaled Ampion for COVID-19 patients

FDA grants IND and approves clinical trial protocol of inhaled Ampion for COVID-19 patients

ENGLEWOOD-- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) announced it has received an Investigational New Drug designation from the U.S. Food and Drug Administration, allowing the company to... Read More

Monday September 21, 2020 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, COVID-19, FDA

SLING TV introduces AirTV Anywhere, featuring whole-home DVR solution and quad tuner for viewing over-the-air channels

SLING TV introduces AirTV Anywhere, featuring whole-home DVR solution and quad tuner for viewing over-the-air channels

ENGLEWOOD -- SLING TV today debuted the latest addition to the AirTV family of devices , AirTV Anywhere — Powered by SLING, a new Wi-Fi-enabled network hub featuring enhanced functionality and... Read More

Friday September 11, 2020 0 comments Tags: Englewood, Sling TV, AirTV Anywhere

Ampio announces enrollment completion for IV COVID-19 clinical trial, update on OAK clinical trial

Ampio announces enrollment completion for IV COVID-19 clinical trial, update on OAK clinical trial

ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) announced enrollment has been completed for the AmpionPhase I US-based clinical trial for IV treatment of COVID-19 patients requiring... Read More

Tuesday September 8, 2020 0 comments Tags: Englewood, Ampio Pharmaceuticals, COVID-19

Paragon 28 launches Phantom ActivCore Hindfoot Nail System that provides constant active compression across the ankle and subtalar joints

Paragon 28 launches Phantom ActivCore Hindfoot Nail System that provides constant active compression across the ankle and subtalar joints

ENGLEWOOD -- Paragon 28 announced it has increased its foot-and-ankle specific portfolio with the addition of the Phantom ActivCore Hindfoot Nail System. The Precision Guided ActivCore Nail... Read More

Friday August 21, 2020 0 comments Tags: Englewood, Paragon 28, ActivCore Nail

Paragon 28 completes Series B financing with Piper Sandler Merchant Banking and MVM Partners

Paragon 28 completes Series B financing with Piper Sandler Merchant Banking and MVM Partners

ENGLEWOOD -- Paragon 28, Inc. announced the completion of a Series B financing. The round was co-led by Piper Sandler Merchant Banking, a commercial stage growth equity investment business of... Read More

Monday August 17, 2020 0 comments Tags: Englewood, Paragon 28, Albert DaCosta

Ampio starts patient enrollment in its Ampion COVID-19 program

Ampio starts patient enrollment in its Ampion COVID-19 program

ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) today announced it is actively working on development of therapies for patients infected with COVID-19. Ampio said patients are... Read More

Thursday July 23, 2020 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, COVID-19